Medium spiny neurons of the nucleus accumbens serve as the interface between corticolimbic regions that elicit and modulate motivated behaviors, including those related to drugs of abuse, and motor regions responsible for their execution. Medium spiny neurons are excited primarily by AMPA-type glutamate receptors, making AMPA receptor transmission in the accumbens a key regulatory point for addictive behaviors. In animal models of cocaine addiction, changes in the strength of AMPA receptor transmission onto accumbens medium spiny neurons have been shown to underlie cocaine-induced behavioral adaptations related to cocaine seeking. Here we review changes in AMPA receptor levels and subunit composition that occur after discontinuing different types of cocaine exposure, as well as changes elicited by cocaine reexposure following abstinence or extinction. Signaling pathways that regulate these cocaine-induced adaptations will also be considered, as they represent potential targets for addiction pharmacotherapies.F unctionally relevant changes in nucleus accumbens glutamatergic transmission induced by psychostimulants (i.e., amphetamine or cocaine) were first identified in the 1990s following two scientific advances: (1) the development of relatively selective AMPA/kainate and NMDA receptor antagonists (Wong et al. 1986;Honore et al. 1988), and (2) a greater appreciation of the influence of glutamatergic afferents to the nucleus accumbens (Albin et al. 1989;Alexander et al. 1990). Studies on the effects of psychostimulants on glutamate transmission were also driven by the realization that the regulated trafficking of glutamate receptors in and out of synapses is a major contributor to changes in synaptic strength during hippocampal synaptic plasticity (Malinow and Malenka 2002).Early studies of glutamate's role in psychostimulant addiction focused primarily on a form of psychostimulant-induced neuronal and behavioral plasticity known as behavioral sensitization wherein repeated exposure to psychostimulants (usually in the form of experimenterdelivered injections) results in a progressive and enduring enhancement of psychostimulant-induced behavioral responses. By the early 1990s,